đŹ Current Disease Focus:
Task Progress: 0%
đĽ Active Problem Solvers
0
đ Experts collaborating globally
⥠Current Task Assignment
𧏠Genetic Analysis
đ Matching experts to specific tasks
đ Resource Allocation by Research Phase:
đ Data Analysis
𧪠Experimental Design
đŹ Clinical Trials
đ Treatment Development
This study aims to evaluate if the application of chlorhexidine gluconate d...
Status
Withdrawn
Location
NYU Langone Health
Start Date
2021-01-01
Trial ID
NCT04656145
Treatments Being Tested
Exit site infection (ESI) is one of the major predisposing factors to perit...
Status
Completed
Location
Allen Liu
Start Date
2019-09-27
Trial ID
NCT06022835
Treatments Being Tested
This is a single-center, prospective, randomized controlled clinical trial ...
Status
Terminated
Location
Ruijin Hospital
Start Date
2021-05-14
Trial ID
NCT04906512
In order to provide treatment in pediatric hematology-oncology patients, in...
Status
Recruiting
Location
GĂźlçin Ăzalp Gerçeker
Start Date
2024-05-07
Trial ID
NCT06720064
Treatments Being Tested
The purpose of this study is to assess the surface cutaneous antimicrobial ...
Status
Completed
Location
Hill Top Research
Start Date
2011-04
Trial ID
NCT01368120
Treatments Being Tested
The purpose of this study is to determine whether contact sensitization occ...
Status
Completed
Location
Hill Top Research
Start Date
2011-03
Trial ID
NCT01368146
Treatments Being Tested
The objective of this study is to assess the efficacy of 3M⢠Tegaderm⢠CHG ...
Status
Completed
Location
Universitätsspital Basel
Start Date
2013-10
Trial ID
NCT02078830
In neutropenic cancer patients, catheter-related bloodstream infections may...
Status
Completed
Location
Klinikum Schwabing
Start Date
2012-02
Trial ID
NCT01544686
Treatments Being Tested
The goal of this clinical trial is to compare a chlorhexidine impregnated d...
Status
Completed
Location
Royal Brisbane and Women's Hospital
Start Date
2023-05-03
Trial ID
NCT05741866
The purpose of this study is to compare the use of chlorhexidine-gel-impreg...
Status
Unknown
Location
Clinical Hospital of RibeirĂŁo Preto Medical School (HCFMRP-USP)
Start Date
2014-04
Trial ID
NCT02472158
Treatments Being Tested